[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100617645":3},{"organization":4,"armGroups":7,"interventions":17,"overallOfficials":23,"centralContacts":27,"locations":37,"responsibleParty":51,"collaborators":10,"id":55,"slug":56,"hasResults":57,"nctId":58,"briefTitle":59,"officialTitle":60,"acronym":10,"eligibilityCriteria":61,"healthyVolunteers":57,"sex":62,"minAge":63,"maxAge":10,"enrollmentInfo":64,"targetDuration":67,"studyType":68,"phases":10,"briefSummary":69,"conditions":70,"keywords":10,"overallStatus":72,"whyStopped":10,"lastUpdateSubmitDate":73,"lastUpdatePostDateStruct":74,"startDateStruct":77,"completionDateStruct":79,"leadSponsor":81,"locationsCount":82},{"fullName":5,"class":6},"Chinese University of Hong Kong","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"RSV group",null,"Patients with respiratory tract infection symptom and RSV confirmed in clinical specimens",[13],"Diagnostic Test: Serial specimen sampling",{"label":15,"type":10,"description":16,"interventionNames":10},"Control group","Patients with respiratory tract infection symptom but no RSV confirmed in clinical specimens",[18],{"type":19,"name":20,"description":21,"armGroupLabels":22,"otherNames":10},"DIAGNOSTIC_TEST","Serial specimen sampling","Serial sampling of nasopharyngeal swab, saliva and sputum for RSV on day 3, 5, 7, 14, 28 (during hospitalization) for patients confirmed with RSV infection. Blood taking will be arranged on day 28 for serology purpose",[9],[24],{"name":25,"affiliation":5,"role":26},"David SC Hui, MD","STUDY_DIRECTOR",[28,33],{"name":29,"role":30,"phone":31,"phoneExt":10,"email":32},"Ka Pang Chan, MBChB","CONTACT","+852 35052211","chankapang@cuhk.edu.hk",{"name":34,"role":30,"phone":35,"phoneExt":10,"email":36},"Karen Yiu","+852 35053532","ysyiu@cuhk.edu.hk",[38],{"facility":5,"status":10,"city":39,"state":10,"zip":10,"country":39,"countryCode":40,"cosmosGeoPoint":41,"geoPoint":46,"contacts":47},"Hong Kong","HK",{"type":42,"coordinates":43},"Point",[44,45],114.17469,22.27832,{"lat":45,"lon":44},[48,49],{"name":29,"role":30,"phone":31,"phoneExt":10,"email":32},{"name":34,"role":30,"phone":50,"phoneExt":10,"email":36},"+852 3505 3532",{"type":52,"investigatorFullName":53,"investigatorTitle":54,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Ka Pang Chan","Professor","100617645","rsv-burden-in-hong-kong-100617645",false,"NCT07321314","RSV Burden in Hong Kong","The Disease Burden of RSV Infection in Hong Kong","Inclusion Criteria:\n\n* Community-acquired respiratory tract infection symptoms\n* Age \\>= 18\n\nExclusion Criteria:\n\n* Unable to provide a good quality of sputum and saliva","ALL","18 Years",{"count":65,"type":66},10000,"ESTIMATED","1 Month","OBSERVATIONAL","RSV infection causes significant mortality and morbidity in susceptible adults. There are many publications on the global RSV disease burden in infants and young children but data on adults are lacking with lots of knowledge gaps. Currently there is no established effective antiviral therapy for RSV. RSV vaccines have recently become available commercially but the Center for Health Protection (Hong Kong) has yet to discuss procurement of RSV vaccines for the high risk groups. Thus a prospective study to assess the disease burden of RSV infection in adults would be of great interest.",[71],"RSV","NOT_YET_RECRUITING","2026-01-06",{"date":75,"type":76},"2026-01-08","ACTUAL",{"date":78,"type":66},"2026-03-01",{"date":80,"type":66},"2028-08-31",{"name":5,"class":6},1]